C
프롬바이오
377220KOSDAQ53.5 / 100
Reference Date: 2026-10-23
Financial Score20.0 / 40
News Sentiment12.5 / 25
Momentum11.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 24.2% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
PromBIO is a comprehensive health functional food company operating the entire value chain, leveraging its ownership of individually certified functional ingredients and R&D capabilities to establish a strong market position. Focusing on its flagship Boswellia and Mastica product lines, the company is expanding into cosmetics and new areas such as cell culture and stem cell research.
Number of Employees
147people
Average Salary
37.9M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
0.49Industry Average 1.207.0Point
Half of industry avg (excellent)
ROE
-61.68Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
7.75Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20251.0 / 10 points
Revenue Growth Rate
1.0 / 3
Avg ▲4.0% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼17.0% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -39.4% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position5.0Point
52w mid range (55%)
Current 2,260Won52-week high 3,68552-week low 513
1-month return0.0Point
1m -24.16% (strong drop)
Volume trend6.0Point
Volume surge
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral주주명부폐쇄기간또는기준일설정2026-10-02
- Neutral주주총회소집결의 (임시주주총회)2026-10-02